» Articles » PMID: 34598786

Computational Modeling of Electroencephalography and Functional Magnetic Resonance Imaging Paradigms Indicates a Consistent Loss of Pyramidal Cell Synaptic Gain in Schizophrenia

Abstract

Background: Diminished synaptic gain-the sensitivity of postsynaptic responses to neural inputs-may be a fundamental synaptic pathology in schizophrenia. Evidence for this is indirect, however. Furthermore, it is unclear whether pyramidal cells or interneurons (or both) are affected, or how these deficits relate to symptoms.

Methods: People with schizophrenia diagnoses (PScz) (n = 108), their relatives (n = 57), and control subjects (n = 107) underwent 3 electroencephalography (EEG) paradigms-resting, mismatch negativity, and 40-Hz auditory steady-state response-and resting functional magnetic resonance imaging. Dynamic causal modeling was used to quantify synaptic connectivity in cortical microcircuits.

Results: Classic group differences in EEG features between PScz and control subjects were replicated, including increased theta and other spectral changes (resting EEG), reduced mismatch negativity, and reduced 40-Hz power. Across all 4 paradigms, characteristic PScz data features were all best explained by models with greater self-inhibition (decreased synaptic gain) in pyramidal cells. Furthermore, disinhibition in auditory areas predicted abnormal auditory perception (and positive symptoms) in PScz in 3 paradigms.

Conclusions: First, characteristic EEG changes in PScz in 3 classic paradigms are all attributable to the same underlying parameter change: greater self-inhibition in pyramidal cells. Second, psychotic symptoms in PScz relate to disinhibition in neural circuits. These findings are more commensurate with the hypothesis that in PScz, a primary loss of synaptic gain on pyramidal cells is then compensated by interneuron downregulation (rather than the converse). They further suggest that psychotic symptoms relate to this secondary downregulation.

Citing Articles

Predictive routing emerges from self-supervised stochastic neural plasticity.

Nejat H, Sherfey J, Bastos A bioRxiv. 2025; .

PMID: 39803482 PMC: 11722284. DOI: 10.1101/2024.12.31.630823.


Glutamate levels and symptom burden in high-risk and first-episode schizophrenia: a dual-voxel study of the anterior cingulate cortex.

Fan L, Zhang Z, Ma X, Liang L, Wang Y, Yuan L J Psychiatry Neurosci. 2024; 49(6):E367-E376.

PMID: 39542650 PMC: 11573428. DOI: 10.1503/jpn.240094.


RDoC Framework Through the Lens of Predictive Processing: Focusing on Cognitive Systems Domain.

Banaraki A, Toghi A, Mohammadzadeh A Comput Psychiatr. 2024; 8(1):178-201.

PMID: 39478691 PMC: 11523845. DOI: 10.5334/cpsy.119.


The neuroscience of mental illness: Building toward the future.

Gordon J, Dzirasa K, Petzschner F Cell. 2024; 187(21):5858-5870.

PMID: 39423804 PMC: 11490687. DOI: 10.1016/j.cell.2024.09.028.


The Many Roles of Precision in Action.

Limanowski J, Adams R, Kilner J, Parr T Entropy (Basel). 2024; 26(9).

PMID: 39330123 PMC: 11431491. DOI: 10.3390/e26090790.


References
1.
Ranlund S, Adams R, Diez A, Constante M, Dutt A, Hall M . Impaired prefrontal synaptic gain in people with psychosis and their relatives during the mismatch negativity. Hum Brain Mapp. 2015; 37(1):351-65. PMC: 4843949. DOI: 10.1002/hbm.23035. View

2.
Hong L, Summerfelt A, McMahon R, Adami H, Francis G, Elliott A . Evoked gamma band synchronization and the liability for schizophrenia. Schizophr Res. 2004; 70(2-3):293-302. DOI: 10.1016/j.schres.2003.12.011. View

3.
Kinon B, Millen B, Zhang L, McKinzie D . Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2/3 receptor agonist pomaglumetad methionil in schizophrenia. Biol Psychiatry. 2015; 78(11):754-62. DOI: 10.1016/j.biopsych.2015.03.016. View

4.
Merritt K, McGuire P, Egerton A, Aleman A, Block W, Bloemen O . Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data. JAMA Psychiatry. 2021; 78(6):667-681. PMC: 8060889. DOI: 10.1001/jamapsychiatry.2021.0380. View

5.
Sivarao D . The 40-Hz auditory steady-state response: a selective biomarker for cortical NMDA function. Ann N Y Acad Sci. 2015; 1344:27-36. DOI: 10.1111/nyas.12739. View